| Post | Subject | | |
|
#2678
|
Reason Why Dr Heymach took a step back
|
antihama
| 10/23/19 06:11:03 PM |
|
#2677
|
While a TDM-1 Pozi Combo trial bodes well
|
antihama
| 10/18/19 08:31:26 AM |
|
#2676
|
Non-Pozi Combo trial This Year Silver Lining Conjecture.
|
antihama
| 10/17/19 12:48:29 PM |
|
#2675
|
“We didn’t want any analysis done until there’s
|
antihama
| 10/16/19 07:39:39 AM |
|
#2674
|
6m after last patient was dosed was ~July
|
antihama
| 10/15/19 12:08:10 PM |
|
#2673
|
Reading about the current vincristine shortage; Marqibo (Vincristine
|
antihama
| 10/15/19 11:46:18 AM |
|
#2672
|
Clarification; each of the passages should have been
|
antihama
| 10/13/19 11:26:04 AM |
|
#2671
|
RE:Publication of Positive Poziotinib Data in Cancer Cell excerpts
|
antihama
| 10/10/19 08:19:03 PM |
|
#2670
|
Publication of Positive Poziotinib Data in Cancer Cell
|
antihama
| 10/04/19 11:08:57 AM |
|
#2669
|
Does the conservative approach bode well for pozi
|
antihama
| 10/03/19 10:05:42 AM |
|
#2668
|
A Zenith20 nugget from Cantor Global HCC's CC
|
antihama
| 10/03/19 07:01:35 AM |
|
#2667
|
Several take homes from the Cantor Global HCC
|
antihama
| 10/02/19 07:43:18 PM |
|
#2666
|
Welcome whytestocks. The clock starts ticking from Oct
|
antihama
| 09/25/19 02:06:49 PM |
|
#2665
|
News: $SPPI Spectrum Pharmaceuticals to Present Corporate Update
|
whytestocks
| 09/25/19 01:30:19 PM |
|
#2664
|
After re-listening to the last part of the
|
antihama
| 09/13/19 05:34:05 PM |
|
#2663
|
OMG! Did no one pick up on what
|
antihama
| 09/13/19 12:14:47 PM |
|
#2662
|
New Sept Presentation updated from July, is the
|
antihama
| 09/13/19 11:08:37 AM |
|
#2661
|
Posi’s a WINNER for Exon 18 atypical P-loop
|
antihama
| 09/07/19 07:27:42 AM |
|
#2660
|
IASLC P1.14-08 - Activity of Poziotinib and Other
|
antihama
| 09/06/19 05:31:41 PM |
|
#2659
|
Spectrum Presenting at Two Investor Conferences; September 10th
|
antihama
| 09/03/19 06:45:54 PM |
|
#2658
|
Yeah, I remember those MEDX days. Advanced degree s
|
antihama
| 08/26/19 06:24:40 PM |
|
#2657
|
I will feel guilty if I won't praise
|
ttp22
| 08/26/19 03:57:19 PM |
|
#2656
|
Thanks PenPen24. Why does Arlo Guthrie's "Alice's Restaurant"
|
antihama
| 08/26/19 01:28:08 PM |
|
#2655
|
Antihama, like BarrellofHay said, please keep posting! I
|
PenPen24
| 08/26/19 08:27:31 AM |
|
#2654
|
OS SoC for 1st-line and Relapsed/refractory patients was
|
antihama
| 08/22/19 10:25:30 PM |
|
#2653
|
RE: Pozi EGFRex20 SoC competition.
|
antihama
| 08/22/19 09:49:50 PM |
|
#2652
|
Sure thing!! I am still getting up to
|
BarrellofHay
| 08/22/19 09:15:40 PM |
|
#2651
|
RE: Comparing TAK-788 and Pozi’s most recent data.
|
antihama
| 08/22/19 08:16:37 PM |
|
#2650
|
Thanks BarrellofHay for the encouragement.
|
antihama
| 08/22/19 07:57:28 AM |
|
#2649
|
Hi Antihama!! Please keep up the great work
|
BarrellofHay
| 08/21/19 11:09:41 PM |
|
#2648
|
40% of total pharma deals involve Kinase Inhibitors
|
antihama
| 08/21/19 05:24:17 PM |
|
#2647
|
Per Elle Investments, Spectrum's an asymmetric risk/reward stock!
|
antihama
| 08/20/19 11:32:27 AM |
|
#2646
|
"Behind The Idea: Spectrum Pharma-Great Asset" SA article
|
antihama
| 08/20/19 11:05:18 AM |
|
#2645
|
Hey, JT, take a cue from CASI’s CEO
|
antihama
| 08/16/19 10:52:37 AM |
|
#2644
|
Discussion on Precision Medicine's from Xconomy
|
antihama
| 08/15/19 11:12:06 AM |
|
#2643
|
Well, one week later I'm posting again. I
|
antihama
| 08/15/19 10:52:19 AM |
|
#2642
|
I know, I know
|
antihama
| 08/11/19 10:04:20 PM |
|
#2641
|
I'm so annoyed about this that I sent
|
antihama
| 08/08/19 11:48:10 AM |
|
#2640
|
Spectrum needs to explain why no interim data
|
antihama
| 08/08/19 11:17:22 AM |
|
#2639
|
Quarterly CC; an explanation on pozi interim data
|
antihama
| 08/07/19 11:18:20 AM |
|
#2638
|
And another thing about Zenith 20 cohort 5.
|
antihama
| 07/25/19 04:09:31 PM |
|
#2637
|
Is the Zenith20 1st-line EGFR cohort fully recruited?
|
antihama
| 07/25/19 03:56:11 PM |
|
#2636
|
I just don't get it! JT and his
|
bsweet8
| 07/25/19 02:52:29 PM |
|
#2635
|
Ha, Ha! Analyst Recommendation; from Sell to Hold
|
antihama
| 07/25/19 07:25:14 AM |
|
#2634
|
Ha! Pozi’s a Coming Right at Ya!
|
antihama
| 07/23/19 08:08:28 AM |
|
#2632
|
NGS fast becoming part of Standard of Care (SOC)
|
antihama
| 07/18/19 08:50:12 PM |
|
#2631
|
Perhaps you think B Riley doesn’t give downgrades
|
antihama
| 07/16/19 10:29:10 AM |
|
#2630
|
RE:Oppenheimer 29th Annual Healthcare Conference CC
|
antihama
| 07/15/19 02:11:11 PM |
|
#2629
|
Rolontis' Good Supplier Management Practices.
|
antihama
| 07/12/19 11:16:55 AM |
|
#2628
|
PS UDENYCA has a 36-month shelf life so
|
antihama
| 07/11/19 05:26:06 PM |
| Post | Subject | | |